Atlas Trials

68Ga-Dotatoc Positron Emission Tomography (PET) for Somatostatin Receptor-Positive Neuroendocrine Tumors (NETs)

Clinical trial NCT02359500 · TERMINATED

Trial details

NCT number
NCT02359500
Sponsor
Lale Kostakoglu
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Neuroendocrine TumorsCarcinoid Tumors
Start date
2014-12-01
Primary completion
2017-01-23
Enrollment
71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.